GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Days Sales Outstanding

Sopharma Trading AD (XBUL:SFT) Days Sales Outstanding : 46.67 (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Days Sales Outstanding?

Sopharma Trading AD's average Accounts Receivable for the three months ended in Sep. 2023 was лв206 Mil. Sopharma Trading AD's Revenue for the three months ended in Sep. 2023 was лв402 Mil. Hence, Sopharma Trading AD's Days Sales Outstanding for the three months ended in Sep. 2023 was 46.67.

The historical rank and industry rank for Sopharma Trading AD's Days Sales Outstanding or its related term are showing as below:

XBUL:SFT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.04   Med: 79.93   Max: 93.65
Current: 43.38

During the past 13 years, Sopharma Trading AD's highest Days Sales Outstanding was 93.65. The lowest was 39.04. And the median was 79.93.

XBUL:SFT's Days Sales Outstanding is ranked better than
81.25% of 96 companies
in the Medical Distribution industry
Industry Median: 77.31 vs XBUL:SFT: 43.38

Sopharma Trading AD's Days Sales Outstanding increased from Sep. 2022 (43.61) to Sep. 2023 (46.67).


Sopharma Trading AD Days Sales Outstanding Historical Data

The historical data trend for Sopharma Trading AD's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Days Sales Outstanding Chart

Sopharma Trading AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.32 71.64 59.14 46.29 39.04

Sopharma Trading AD Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.61 39.49 40.68 43.84 46.67

Competitive Comparison of Sopharma Trading AD's Days Sales Outstanding

For the Medical Distribution subindustry, Sopharma Trading AD's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Days Sales Outstanding falls into.



Sopharma Trading AD Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sopharma Trading AD's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (155.884 + 160.405) / 2 ) / 1478.508*365
=158.1445 / 1478.508*365
=39.04

Sopharma Trading AD's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (180.236 + 231.231) / 2 ) / 402.254*365 / 4
=205.7335 / 402.254*365 / 4
=46.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma Trading AD  (XBUL:SFT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Sopharma Trading AD Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD (XBUL:SFT) Business Description

Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines